
    
      This is a randomized, observer blind, non-inferior, parallel group, multi-centre clinical
      study to determine and compare immunogenicity and reactogenicity of DTP-HB-Hib vaccine of
      Serum Institute of India Ltd. delivered either with disposable-Syringe Jet Injector (DSJI) or
      disposable-syringe needle in total 340 Indian infants. Sera samples will be analyzed by ELISA
      for seroconversion / seropositivity for each individual component of vaccine i.e. Diphtheria,
      Tetanus, Pertussis, Hepatitis B (HBsAg) and Hemophilus Influenza B at 28 days after
      administration of a third dose of the vaccine.
    
  